Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 387
Gene Symbol: RHOA
RHOA
0.300 Biomarker disease CTD_human Postzygotic inactivating mutations of RHOA cause a mosaic neuroectodermal syndrome. 31570889 2019
Entrez Id: 947
Gene Symbol: CD34
CD34
0.020 Biomarker disease BEFREE Vascular Endothelial Growth Factor Protects CD200-Rich and CD34-Positive Hair Follicle Stem Cells Against Androgen-Induced Apoptosis Through the Phosphoinositide 3-Kinase/Akt Pathway in Patients With Androgenic Alopecia. 31478937 2020
Entrez Id: 1308
Gene Symbol: COL17A1
COL17A1
0.010 Biomarker disease BEFREE COL17A1 proteolysis stimulated hair-follicle stem-cell aging, characterized by the loss of stemness signatures and hair-follicle miniaturization associated with androgenic alopecia. 31383286 2019
Entrez Id: 367
Gene Symbol: AR
AR
0.500 Biomarker disease BEFREE Comparative full transcriptome profile analysis of the hair bulb region of normal and miniaturized hair follicles from vertex and occipital region in males with and without androgenetic alopecia revealed that next to the androgen receptor as well the retinoid receptor and particularly the PPAR pathway is involved in progressive hair miniaturization. 31217429 2019
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.010 Biomarker disease BEFREE Comparative full transcriptome profile analysis of the hair bulb region of normal and miniaturized hair follicles from vertex and occipital region in males with and without androgenetic alopecia revealed that next to the androgen receptor as well the retinoid receptor and particularly the PPAR pathway is involved in progressive hair miniaturization. 31217429 2019
Entrez Id: 22943
Gene Symbol: DKK1
DKK1
0.030 AlteredExpression disease BEFREE Dickkopf-1 Expression in Androgenetic Alopecia and Alopecia Areata in Male Patients. 30640755 2019
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
0.020 AlteredExpression disease BEFREE Efficacy of 1,550-nm Erbium-Glass Fractional Laser Treatment and Its Effect on the Expression of Insulin-Like Growth Factor 1 and Wnt/β-Catenin in Androgenetic Alopecia. 30096107 2018
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.020 Biomarker disease BEFREE Efficacy of 1,550-nm Erbium-Glass Fractional Laser Treatment and Its Effect on the Expression of Insulin-Like Growth Factor 1 and Wnt/β-Catenin in Androgenetic Alopecia. 30096107 2018
Entrez Id: 367
Gene Symbol: AR
AR
0.500 AlteredExpression disease BEFREE In this commentary, we use microcompetition to explain how common latent viruses can cause transcription factor deficiency, overexpression of 5α-reductase and AR, and male-pattern baldness. 30019525 2018
Entrez Id: 221037
Gene Symbol: JMJD1C
JMJD1C
0.010 GeneticVariation disease BEFREE We assessed genetic associations of variants in two gene regions (SHBG and JMJD1C) with several cardiovascular risk factors (lipids, adiponectin, blood pressure, anthropometric traits) plus male pattern baldness, including control outcomes and potential mediators. 29804699 2018
Entrez Id: 6462
Gene Symbol: SHBG
SHBG
0.010 GeneticVariation disease BEFREE We assessed genetic associations of variants in two gene regions (SHBG and JMJD1C) with several cardiovascular risk factors (lipids, adiponectin, blood pressure, anthropometric traits) plus male pattern baldness, including control outcomes and potential mediators. 29804699 2018
Entrez Id: 1401
Gene Symbol: CRP
CRP
0.010 Biomarker disease BEFREE We measured the plasma level of two common cardiovascular disease markers, cardiac troponin I and C-reactive protein, in alopecia areata and androgenetic alopecia affected subjects. 29740659 2018
Entrez Id: 367
Gene Symbol: AR
AR
0.500 AlteredExpression disease BEFREE This review describes recent studies on the role of androgens and androgen receptor (AR) transactivation activity in modulating the Wnt/β-catenin signaling in the dermal papilla cells of the balding scalp in androgenetic alopecia. 29549490 2018
Entrez Id: 2247
Gene Symbol: FGF2
FGF2
0.010 Biomarker disease BEFREE We present four cases of androgenetic alopecia that underwent treatment with a non-ablative erbium glass fractional laser followed by the application of topical finasteride 0,05% and growth factors including basic fibroblast growth factor, insulin-like growth factor, vascular endothelial growth factor, and copper peptide 1%. 29452017 2019
Entrez Id: 7001
Gene Symbol: PRDX2
PRDX2
0.010 Biomarker disease BEFREE Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia. 29443105 2018
Entrez Id: 722
Gene Symbol: C4BPA
C4BPA
0.010 Biomarker disease BEFREE Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia. 29443105 2018
Entrez Id: 79092
Gene Symbol: CARD14
CARD14
0.010 Biomarker disease BEFREE Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia. 29443105 2018
Entrez Id: 5621
Gene Symbol: PRNP
PRNP
0.010 Biomarker disease BEFREE Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia. 29443105 2018
Entrez Id: 10058
Gene Symbol: ABCB6
ABCB6
0.010 Biomarker disease BEFREE Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia. 29443105 2018
Entrez Id: 5573
Gene Symbol: PRKAR1A
PRKAR1A
0.300 Biomarker disease CTD_human PKA signaling drives reticularis differentiation and sexually dimorphic adrenal cortex renewal. 29367455 2018
Entrez Id: 354
Gene Symbol: KLK3
KLK3
0.020 AlteredExpression disease BEFREE Serum androgens and prostate-specific antigen levels in androgenetic alopecia: is there a difference between frontal and vertex baldness? 29237093 2018
Entrez Id: 9734
Gene Symbol: HDAC9
HDAC9
0.110 GeneticVariation disease GWASCAT GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk. 29146897 2017
Entrez Id: 2250
Gene Symbol: FGF5
FGF5
0.110 GeneticVariation disease GWASCAT GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk. 29146897 2017
Entrez Id: 3646
Gene Symbol: EIF3E
EIF3E
0.100 GeneticVariation disease GWASCAT GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk. 29146897 2017
Entrez Id: 83938
Gene Symbol: LRMDA
LRMDA
0.100 GeneticVariation disease GWASCAT GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk. 29146897 2017